The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro
- PMID: 7854975
- DOI: 10.1016/0196-9781(94)90147-3
The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro
Abstract
Neither pituitary adenylate cyclase activating polypeptide-38 (PACAP) nor its homologue, vasoactive intestinal polypeptide (VIP), contracted guinea pig isolated trachea (GPT), but on preparations contracted with KCl (40 mM), both caused concentration-related relaxation (3 nM-3 microM, VIP IC50 = 72 nM, PACAP IC50 = 224 nM). Relaxant curves to PACAP were slower in reaching a maximum than those to VIP (approximately 150 and 50 min, respectively). The protease inhibitors, phosphoramidon (1 microM), leupeptin (50 microM), bestatin (100 microM), soya bean trypsin inhibitor (1 microM), and aprotinin (5 microM), together caused a small enhancement of relaxations to VIP, but not to PACAP. The VIP antagonist, [4-Cl-D-Phe6, Leu17]VIP (1-10 microM), did not inhibit the relaxation to either peptide, but did cause large contractions, which were enhanced by protease inhibition. These findings demonstrate that PACAP relaxes GPT in a similar manner to VIP.
Similar articles
-
Relaxant effects of pituitary adenylate cyclase activating polypeptide (PACAP) on epithelium-intact and -denuded guinea-pig trachea: a comparison with vasoactive intestinal peptide (VIP).Neuropeptides. 1995 Sep;29(3):121-7. doi: 10.1016/0143-4179(95)90013-6. Neuropeptides. 1995. PMID: 8538872
-
The effects of IAPP and CGRP on guinea pig tracheal smooth muscle in vitro.Peptides. 1994;15(7):1243-7. doi: 10.1016/0196-9781(94)90148-1. Peptides. 1994. PMID: 7854976
-
A novel PACAP 1-27 analogue causes sustained smooth muscle relaxation in guinea-pig trachea.Ann N Y Acad Sci. 1996 Dec 26;805:536-42. doi: 10.1111/j.1749-6632.1996.tb17515.x. Ann N Y Acad Sci. 1996. PMID: 8993435 No abstract available.
-
PACAP-(6-38) inhibits the effects of vasoactive intestinal polypeptide, but not PACAP, on the small intestinal circular muscle.Eur J Pharmacol. 2001 Nov 16;431(2):259-64. doi: 10.1016/s0014-2999(01)01451-0. Eur J Pharmacol. 2001. PMID: 11728434
-
VIP/PACAP signaling as an alternative target during hyperoxic exposure in preterm newborns.Physiol Res. 2021 Aug 31;70(4):489-499. doi: 10.33549/physiolres.934638. Epub 2021 Jun 1. Physiol Res. 2021. PMID: 34062074 Free PMC article. Review.
Cited by
-
Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma.Thorax. 2003 Mar;58(3):217-21. doi: 10.1136/thorax.58.3.217. Thorax. 2003. PMID: 12612296 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources